Literature DB >> 26733771

Hepcidin/Ferritin Quotient Helps to Predict Spontaneous Recovery from Iron Loss following Blood Donation.

Ramin Lotfi1, Christine Kroll2, Dietmar Plonné3, Bernd Jahrsdörfer1, Hubert Schrezenmeier1.   

Abstract

BACKGROUND: Iron supplementation is generally recommended for blood donors even though there are inter-individual differences in iron homeostasis.
METHODS: Ferritin levels of repeat donors were compared with first-time donors, retrospectively. Prospectively, we tested 27 male repeat donors for the following parameters at the day of blood donation as well as 1, 3, 7, 10, and 56 days thereafter: ferritin, hepcidin, transferrin, transferrin receptor, hemoglobin, erythropoietin, reticulocytes, hemoglobin in reticulocyte, twisted gastrulation protein homolog 1, and growth differentiation factor-15.
RESULTS: 56 days after blood donation, donors' average ferritin dropped to 55% (range 30-100%) compared to the initial value. Of all tested parameters hepcidin showed the highest and most significant changes beginning 1 day after donation and lasting for the whole period of 56 days. Along with ferritin, there was a high variation in hepcidin levels indicating inter-individual differences in hepcidin response to iron loss. Donors with a hepcidin/ferritin quotient < 0.3 regained 60% of their initial ferritin after 56 days, while those with a quotient ≥ 0.3 reached less than 50%.
CONCLUSION: As hepcidin appears to integrate erythropoietic and iron-loading signals, clinical measurement of hepcidin (together with the hepcidin-ferritin ratio) may become a useful indicator of erythropoiesis and iron kinetics.

Entities:  

Keywords:  Donors; Health research methodology; Hematology; Red cells

Year:  2015        PMID: 26733771      PMCID: PMC4698650          DOI: 10.1159/000440825

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  37 in total

1.  A clinical evaluation of the Hemocue haemoglobinometer using capillary, venous and arterial samples.

Authors:  P P Chen; T G Short; D H Leung; T E Oh
Journal:  Anaesth Intensive Care       Date:  1992-11       Impact factor: 1.669

2.  The impact of temporary deferral due to low hemoglobin: future return, time to return, and frequency of subsequent donation.

Authors:  Tessa Hillgrove; Vivienne Moore; Kathleen Doherty; Philip Ryan
Journal:  Transfusion       Date:  2010-09-16       Impact factor: 3.157

Review 3.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

4.  A noninvasive strategy for screening prospective blood donors for anemia.

Authors:  Ramin Lotfi; Dorothee Wernet; Uwe Starke; Hinnak Northoff; Uwe Cassens
Journal:  Transfusion       Date:  2005-10       Impact factor: 3.157

Review 5.  Soluble transferrin receptor for the evaluation of erythropoiesis and iron status.

Authors:  Yves Beguin
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

6.  Demographic correlates of low hemoglobin deferral among prospective whole blood donors.

Authors:  Alan E Mast; Karen S Schlumpf; David J Wright; Brian Custer; Bryan Spencer; Edward L Murphy; Toby L Simon
Journal:  Transfusion       Date:  2010-04-15       Impact factor: 3.157

7.  Effect of iron deficiency on succinate- and NADH-ubiquinone oxidoreductases in skeletal muscle mitochondria.

Authors:  B A Ackrell; J J Maguire; P R Dallman; E B Kearney
Journal:  J Biol Chem       Date:  1984-08-25       Impact factor: 5.157

8.  Iron stores and iron absorption: effects of repeated blood donations.

Authors:  P J Garry; K M Koehler; T L Simon
Journal:  Am J Clin Nutr       Date:  1995-09       Impact factor: 7.045

9.  High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin.

Authors:  A Mireille Baart; Paulus A H van Noord; Yvonne Vergouwe; Karel G M Moons; Dorine W Swinkels; Erwin T Wiegerinck; Wim L A M de Kort; Femke Atsma
Journal:  Transfusion       Date:  2012-11-26       Impact factor: 3.157

10.  Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells.

Authors:  Toshihiko Tanno; Prashanth Porayette; Orapan Sripichai; Seung-Jae Noh; Colleen Byrnes; Ajoy Bhupatiraju; Y Terry Lee; Julia B Goodnough; Omid Harandi; Tomas Ganz; Robert F Paulson; Jeffery L Miller
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

View more
  2 in total

1.  Iron supplementation limits the deleterious effects of repeated blood donation on endurance sport performance but not on iron status.

Authors:  Barbara Pachikian; Damien Naslain; Nicolas Benoit; Romain Brebels; Kristin Van Asch; Veerle Compernolle; Philippe Vandekerckhove; Louise Deldicque
Journal:  Blood Transfus       Date:  2020-07-22       Impact factor: 3.443

2.  Molecular analysis of homeostatic iron regulator, transmembrane protease serine-6, and BTB domain-containing protein-9 variants and iron parameters in blood donors.

Authors:  Manal S Fawzy; Abeer Fakhr-Eldeen; Baraah T Abu AlSel; Eman A Toraih
Journal:  Biosci Rep       Date:  2021-01-29       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.